Comparison of various formulae for estimating low-density lipoprotein cholesterol by a combination of ages and genders in Taiwanese adults

BMC Cardiovascular Disorders

Shao-Jen Weng²  Hsin-Hung Wu³  Chung-Huang Tsai¹ 

[1] Department of Family Medicine, Chung-Kang Branch, Cheng Ching General Hospital, Taichung 40799, Taiwan;Department of Industrial Engineering and Enterprise Information, Tunghai University, Taichung 40704, Taiwan;Department of Business Administration, National Changhua University of Education, Changhua 500, Taiwan

关键词: Triglyceride;    Friedewald formula;    Residual cholesterol;    Low-density lipoprotein cholesterol;   

Others  :  1088459
DOI  :  10.1186/1471-2261-14-113

 received in 2014-05-08, accepted in 2014-08-22,  发布年份 2014

【 摘 要 】

Background

The accuracy and precision of the Friedewald formula for estimating low-density lipoprotein cholesterol (LDL-C) is questionable. Although other formulae have been developed, only a few studies compare them. Thus, we compared the efficiencies of various formulae, based on the age and gender of adults, to determine which ones yield more accurate estimations in terms of mean squared error, and which formulae underestimated and overestimated LDL-C performance.

Methods

This study compares various formulae in terms of mean squared error (MSE), as well as underestimation and overestimation of LDL-C concentrations, using subjects of various ages and both genders. Six groups were examined in this study based on age and gender: males 20–44 years old, 45–64, and 65 and above, and females in the same three age ranges.

Results

The results show that the Friedewald formula has relatively low accuracy, and while its performance among older (aged 45 and above) women with triglyceride concentrations ≤ 400 mg/dL is better than that with other groups, it is still more inaccurate than the other formulae. In terms of prediction errors and mean squared errors, Tsai’s formula (TF) and a calibrated TF provide the most accurate results with regard to the LDL-C concentration. Moreover, based on a cross-validation of age and gender, these two formulae provide highly accurate results for the LDL-C concentrations of all the studied groups, except for women aged 20–44 years.

Conclusions

Based on the experimental results, this study provides a set of benchmarks for the formulae used in LDL-C tests when considering the factors of age and gender. Therefore, it is a valuable method for providing formula benchmarking.

【 授权许可】

   
2014 Tsai et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

【 参考文献 】

• [1]National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002, 106:3143-3421.
• [2]Teramoto T, Sasaki J, Ueshima H, Egusa G, Kinoshita M, Shimamoto K, Daida H, Biro S, Hirobe K, Funahashi T, Yokote K, Yokode M: Executive summary of Japan Atherosclerosis Society (JAS) guideline for diagnosis and prevention of atherosclerotic cardiovascular diseases for Japanese. J Atheroscler Thromb 2007, 14:45-50.
• [3]Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972, 18:499-502.
• [4]DeLong DM, DeLong ER, Wood PD, Lippel K, Rifkind BM: A comparison of methods for the estimation of plasma low- and very-low-density lipoprotein cholesterol. The Lipid Research Clinics Prevalence Study. JAMA 1986, 256:2372-2377.
• [5]Teerakanchana T, Puavilai W, Suriyaprom K, Tungtrongchitr R: Comparative study of LDL cholesterol levels in Thai patients by the direct method and using the Friedewald formula. Southeast Asian J Trop Med Public Health 2007, 38:519-527.
• [6]Balal M, Paydas S, Inal T, Demir E, Kurt C, Sertdemir Y: Validation of the Friedewald formula for the determination of low-density lipoprotein cholesterol in renal transplant recipients. Ren Fail 2010, 32:455-458.
• [7]Tsai C-H, Su J-L, Wu M-H, Huang C-J, Lin J-L: Estimating low-Density lipoprotein cholesterol by a new formula instead of the Friedewald formula in Adult Taiwanese. Taiwan J Fam Med 2013, 23:1-14.
• [8]Tsai C-H, Lin H-Y, Wang H-F, Wang J, Gau-De L, Jiunn-Lung L: Comparison of the efficiencies of various formulae for estimating low-density lipoprotein cholesterol in Adult Taiwanese. Nutr Sci J 2012, 37(4):119-127.
• [9]Wilson PW, D’Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB: Prediction of coronary heart disease using risk factor categories. Circulation 1998, 97:1837-1847.
• [10]Sharrett AR, Ballantyne CM, Coady SA, Heiss G, Sorlie PD, Catellier D, Patsch W: Coronary heart disease prediction from lipoprotein cholesterol concentrations, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: the Atherosclerosis Risk in Communities (ARIC) study. Circulation 2001, 104:1108-1113.
• [11]Okamura T, Kokubo Y, Watanabe M, Higashiyama A, Miyamoto Y, Yoshimasa Y, Okayama A: Low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol and the incidence of cardiovascular disease in an urban Japanese cohort study: the Suita study. Atherosclerosis 2009, 203:587-592.
• [12]Maruyama K, Hirobe K, Noda H, Iso H, Dohi S, Terai T, Fujioka S, Goto K, Horie S, Nakano S: Associations between blood lipid profiles and risk of myocardial infarction among Japanese male workers: 3M study. J Atheroscler Thromb 2009, 16:714-721.
• [13]Mora S, Rifai N, Buring JE, Ridker PM: Comparison of LDL cholesterol concentrations by Friedewald’s calculation and direct measurement in relation to cardiovascular events in 27,331 women. Clin Chem 2009, 55:888-894.
• [14]Faas FH, Earleywine A, Smith G, Simmons DL: How should low-density lipoprotein cholesterol concentration be determined? J Fam Pract 2002, 51:972-975.
• [15]Tighe DA, Ockene IS, Reed G, Nicolosi R: Calculated low-density lipoprotein cholesterol levels frequently underestimate directly measured low-density lipoprotein cholesterol determinations in patients with serum triglyceride levels < or = 4.52 mmol/l: an analysis comparing the LipiDirect magnetic LDL assay with the Friedewald calculation. Clin Chim Acta 2006, 365:236-242.
• [16]Can M, Acikgoz S, Mungan G, Ugurbas E, Ankarali H, Sumbuloglu V, Demirtas S, Karaca L: Is direct method of low-density lipoprotein cholesterol measurement appropriate for targeting lipid-lowering therapy? Int J Cardiol 2010, 142:105-107.
• [17]Cordova CM, Schneider CR, Juttel ID, Cordova MM: Comparison of LDL cholesterol direct measurement with the estimate using the Friedewald’s formula in a sample of 10,664 patients. Arq Bras Cardiol 2004, 83(6):482-487. 76–81
• [18]Jun KR, Park HI, Chun S, Park H, Min WK: Effects of total cholesterol and triglyceride on the percentage difference between the low-density lipoprotein cholesterol concentration measured directly and calculated using the Friedewald formula. CCLM / FESCC 2008, 46:371-375.
• [19]Eblen-Zajjur A, Eblen-Zajjur M: Estimation of low-density lipoprotein-cholesterol concentration: regression analysis versus Friedewald’s formula. Rev Med Chil 2001, 129:1263-1270.
• [20]Tremblay AJ, Morrissette H, Gagne JM, Bergeron J, Gagne C, Couture P: Validation of the Friedewald formula for the determination of low-density lipoprotein cholesterol compared with beta-quantification in a large population. Clin Biochem 2004, 37:785-790.
• [21]Marniemi J, Maki J, Maatela J, Jarvisalo J, Impivaara O: Poor applicability of the Friedewald formula in the assessment of serum LDL cholesterol for clinical purposes. Clin Biochem 1995, 28:285-289.
• [22]Davidson M, Liu SX, Barter P, Brinton EA, Cannon CP, Gotto AM Jr, Leary ET, Shah S, Stepanavage M, Mitchel Y, Dansky HM: Measurement of LDL-C after treatment with the CETP inhibitor anacetrapib. Journal of LIPID Research 2013, 54:467-472.
• [23]Fredrickson DS, Levy RI, Lees RS: Fat transport in lipoproteins–an integrated approach to mechanisms and disorders. N Engl J Med 1967, 276:34-44.
• [24]Hatch FT: Practical methods for plasma lipoprotein analysis. Adv Lipid Res 1968, 6:1-68.
• [25]McNamara JR, Cohn JS, Wilson PW, Schaefer EJ: Calculated values for low-density lipoprotein cholesterol in the assessment of lipid abnormalities and coronary disease risk. Clin Chem 1990, 36:36-42.
• [26]Lai HS, Liu WJ, Chen CY: Study on the accuracy of using the Friedewald formula in predicting serum low-density lipoprotein level in Taiwan. Tw Fam Med Res 2004, 2:10-19.
• [27]Cohn JS, McNamara JR, Cohn SD, Ordovas JM, Schaefer EJ: Postprandial plasma lipoprotein changes in human subjects of different ages. J Lipid Res 1988, 29:469-479.
• [28]Weintraub MS, Zechner R, Brown A, Eisenberg S, Breslow JL: Dietary polyunsaturated fats of the W-6 and W-3 series reduce postprandial lipoprotein levels. Chronic and acute effects of fat saturation on postprandial lipoprotein metabolism. J Clin Invest 1988, 82:1884-1893.